T-Pharma Limited 09469761 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is Wholesale of pharmaceutical goods Digita Accounts Production Advanced 6.30.9574.0 true 09469761 2024-04-01 2025-03-31 09469761 2025-03-31 09469761 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09469761 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 09469761 bus:Micro-entities 2024-04-01 2025-03-31 09469761 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09469761 bus:FilletedAccounts 2024-04-01 2025-03-31 09469761 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09469761 bus:RegisteredOffice 2024-04-01 2025-03-31 09469761 bus:Director1 2024-04-01 2025-03-31 09469761 bus:Director2 2024-04-01 2025-03-31 09469761 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09469761 countries:AllCountries 2024-04-01 2025-03-31 09469761 2023-04-01 2024-03-31 09469761 2024-03-31 09469761 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 09469761 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 iso4217:GBP xbrli:pure

Registration number: 09469761

T-Pharma Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 March 2025

 

T-Pharma Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

T-Pharma Limited

Company Information

Directors

Mr Anthony Mills

Mrs Jennifer Mills

Registered office

The Coach House
56 West Avenue
Walton
Warrington
WA4 6GH

Accountants

Davidson Stant Limited
The Glen
Knutsford Old Road
Stockton Heath
Warrington
Cheshire
WA4 2LD

 

T-Pharma Limited

(Registration number: 09469761)
Balance Sheet as at 31 March 2025

2025
£

2024
£

Fixed assets

60,901

354,367

Current assets

492,349

98,901

Prepayments and accrued income

1,686

2,031

Creditors: Amounts falling due within one year

(152,063)

(85,070)

Net current assets

341,972

15,862

Total assets less current liabilities

402,873

370,229

Creditors: Amounts falling due after more than one year

(5,011)

(25,577)

Accruals and deferred income

(4,312)

(3,024)

 

393,550

341,628

Capital and reserves

393,550

341,628

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2024 - 3).

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 8 June 2025 and signed on its behalf by:
 

 

T-Pharma Limited

(Registration number: 09469761)
Balance Sheet as at 31 March 2025

.........................................
Mr Anthony Mills
Director